Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms
Key facts
- Who runs it
- Shanghai Jiao Tong University School of Medicine
- Where
- China26 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 2,242 people, planned
- Started
- 11 Mar 2024
- Planned end
- 31 May 2025
- Type of study
- Observational
- Treatments tested
- Epidemiological questionnaire and Functional Dyspepsia Symptom Diary(FDSD)
- Record updated
- 30 December 2024
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Male or female patients aged 18-80 years
- H. pylori infection diagnosed by 13C/ 14C-UBT (> 2 times the cutoff value) and/or gastroscopy (rapid urease strong positive and histological positive)
- Treatment-naive patients with Helicobacter pylori
- Ability and willingness to participate in the study and to sign and give informed consent
Who cannot take part
- Organic digestive diseases, such as active peptic ulcer, gastroesophageal reflux, gastrointestinal bleeding, acute/chronic pancreatitis, acute/chronic cholecystitis, gallstones, intestinal obstruction, inflammatory bowel disease, etc
- History of cancer
- History of subtotal gastrectomy
- Severe organ dysfunction of heart, liver, kidney, lung and other important organs and congenital diseases, such as grade IV heart failure, liver failure, uremia, respiratory failure, hemophilia, Wilson's disease, etc
- Under 18 or over 80 years old
- Combined with melena, hematemesis, anemia, emaciation and other alarm symptoms
- Pregnant and lactating women
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objectives of this multicenter, prospective, observational study were to investigate the incidence of dyspeptic symptoms in patients with Helicobacter pylori (H. pylori) infection and to continuously follow up the remission of dyspeptic symptoms after H. pylori eradication, so as to provide reference for the clinical diagnosis and treatment strategies of patients with H. pylori infection and dyspeptic symptoms.
The group in the trial
- Dyspepsia with Helicobacter pylori infection
Treatment: Epidemiological questionnaire and Functional Dyspepsia Symptom Diary(FDSD)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06422052, who can take part
- Record updated
- 30 December 2024